Both in Biotechnology
MeiraGTx Holdings vs Cullinan Therapeutics
Over the past year MGTX returned +4.5% and CGEM returned +73.6%; their daily moves had a correlation of 0.40.
MGTX +4.5% CGEM +73.6%Growth of $1, one year, split-adjusted
| Metric | MGTX | CGEM |
|---|---|---|
| Price | $9.49 | $15.03 |
| Market cap | $911.4M | $967.3M |
| Today | −2.22% | −2.72% |
| 1 month | −11.0% | +3.4% |
| 6 months | +0.9% | +11.9% |
| Year to date | +19.4% | +45.2% |
| 1 year | +6.3% | +95.4% |
| Revenue growth (YoY) | +8608.6% | — |
| Gross margin | 97.8% | — |
| Net margin | 50.0% | — |
| P/E (TTM) | 11.5× | — |
| Price / sales | 2.3× | — |
| Net cash | $21.8M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 47.5% | 75.4% |
| Short % of float | 10.8% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).